Premium
Fenfluramine as add‐on therapy for Dravet syndrome
Author(s) -
Chaplin Steve
Publication year - 2021
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1949
Subject(s) - dravet syndrome , medicine , fenfluramine , epilepsy , psychiatry , receptor , serotonin
Fenfluramine (Fintepla) has recently been licensed as add‐on therapy for the treatment of seizures associated with Dravet syndrome. This article summarises its clinical trial efficacy and adverse effects.